期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 55, 期 6, 页码 3031-3035出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01569-10
关键词
-
资金
- Pfizer Pharmaceutical Group, Italy
We tested the activities of anidulafungin and other antifungal agents against clinical isolates of different fungal species. For Candida species, high sessile MIC(90)s (SMIC(90)s) were obtained for fluconazole, voriconazole, and amphotericin B, whereas the anidulafungin SMIC(90)s were very low, as were those for caspofungin. Comparatively, for Aspergillus species, higher SMIC(90) values were obtained not only for amphotericin B and voriconazole but also for the echinocandins.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据